Profusa, a company that is developing connected tissue-implanted biosensors, has raised just over $45 million in Series C funding. Participants in the round included new investors VMS Investment Group, Tasly Pharmaceutical Group, and Maxim Integrated, as well as returning backers 3E Bioventures Capital and Atinum Investment.
The company will be using the new financing to bring its CE Marked...
The Qualcomm Foundation announced this week that it had awarded the Scripps Translational Science Institute (STSI) $3.75 million to fund clinical trials focused on wireless biosensor systems, rapid pharmacogenomic diagnostic tests, and apps and embedded sensors for tracking and predicting heart attacks, Type 1 diabetes and some types of cancer. The monies will help fund three years of research...
